Its increase in the present study aligns with the literature that found ischemic stroke patients exhibit significantly higher SHMT1 promoter methylation compared to healthy controls, which is strongly associated with elevated plasma homocysteine levels. The gene discussed is SHMT1; the disease is ischemic stroke.